(Q38152297)

29 August 2017

title

The pivotal role of microRNA-155 in the control of cancer (English)

1 reference

29 August 2017

1 reference

Zhaolin Chen

1

1 reference

29 August 2017

Taotao Ma

2

1 reference

29 August 2017

Cheng Huang

3

1 reference

29 August 2017

Tingting Hu

4

1 reference

29 August 2017

Jun Li

5

1 reference

29 August 2017

language of work or name

1 reference

1 May 2014

1 reference

Journal of Cellular Physiology

29 August 2017

published in

1 reference

29 August 2017

volume

229

1 reference

29 August 2017

issue

5

1 reference

29 August 2017

page(s)

545-550

1 reference

Neurotensin signaling activates microRNAs-21 and -155 and Akt, promotes tumor growth in mice, and is increased in human colon tumors

29 August 2017

cites work

1 reference

MicroRNAs: genomics, biogenesis, mechanism, and function

21 January 2018

1 reference

MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.

21 January 2018

1 reference

The complexities of microRNA regulation: mirandering around the rules

21 January 2018

1 reference

p53-Repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation.

21 January 2018

1 reference

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

21 January 2018

1 reference

Clinical significance of microRNA-155 expression in human breast cancer

21 January 2018

1 reference

Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice

21 January 2018

1 reference

MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways

21 January 2018

1 reference

SOCS1 is significantly up-regulated in Nutlin-3-treated p53wild-type B chronic lymphocytic leukemia (B-CLL) samples and shows an inverse correlation with miR-155.

21 January 2018

1 reference

Upregulation of MiR-155 in nasopharyngeal carcinoma is partly driven by LMP1 and LMP2A and downregulates a negative prognostic marker JMJD1A.

21 January 2018

1 reference

Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

21 January 2018

1 reference

Accumulation of miR-155 and BIC RNA in human B cell lymphomas

21 January 2018

1 reference

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status

21 January 2018

1 reference

Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia

21 January 2018

1 reference

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development

21 January 2018

1 reference

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

21 January 2018

1 reference

Mammalian microRNAs predominantly act to decrease target mRNA levels

21 January 2018

1 reference

Up-regulation of microRNA-155 promotes cancer cell invasion and predicts poor survival of hepatocellular carcinoma following liver transplantation

21 January 2018

1 reference

Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer

21 January 2018

1 reference

Quantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphoma

21 January 2018

1 reference

MicroRNA gene expression deregulation in human breast cancer

21 January 2018

1 reference

MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene

21 January 2018

1 reference

A novel miR-155/miR-143 cascade controls glycolysis by regulating hexokinase 2 in breast cancer cells

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1.

21 January 2018

1 reference

MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer

21 January 2018

1 reference

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer.

21 January 2018

1 reference

MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA

21 January 2018

1 reference

Identification of tissue-specific microRNAs from mouse

21 January 2018

1 reference

MicroRNA-155 targets the SKI gene in human melanoma cell lines

21 January 2018

1 reference

Putative tumor suppressor gene SEL1L was downregulated by aberrantly upregulated hsa-mir-155 in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer

21 January 2018

1 reference

Serum circulating microRNA profiling for identification of potential breast cancer biomarkers

21 January 2018

1 reference

Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients

21 January 2018

1 reference

MicroRNA-146a negatively regulates the immunoregulatory activity of bone marrow stem cells by targeting prostaglandin E2 synthase-2.

21 January 2018

1 reference

Cooperative control of tumor suppressor genes by a network of oncogenic microRNAs

21 January 2018

1 reference

High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma

21 January 2018

1 reference

Clinical applications for microRNAs in cancer

21 January 2018

1 reference

microRNA expression patterns reveal differential expression of target genes with age.

21 January 2018

1 reference

Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma

21 January 2018

1 reference

MiR-224 impairs adipocyte early differentiation and regulates fatty acid metabolism

21 January 2018

1 reference

Repression of protein synthesis by miRNAs: how many mechanisms?

21 January 2018

1 reference

Cisplatin sensitivity mediated by WEE1 and CHK1 is mediated by miR-155 and the miR-15 family

21 January 2018

1 reference

MicroRNA-155 is a novel suppressor of ovarian cancer-initiating cells that targets CLDN1.

21 January 2018

1 reference

Targeting of SMAD5 links microRNA-155 to the TGF-beta pathway and lymphomagenesis

21 January 2018

1 reference

Oncogenic microRNA-155 down-regulates tumor suppressor CDC73 and promotes oral squamous cell carcinoma cell proliferation: implications for cancer therapeutics

21 January 2018

1 reference

Overexpression of miR-142-5p and miR-155 in gastric mucosa-associated lymphoid tissue (MALT) lymphoma resistant to Helicobacter pylori eradication

21 January 2018

1 reference

miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model

21 January 2018

1 reference

A brain-specific microRNA regulates dendritic spine development

21 January 2018

1 reference

Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer.

21 January 2018

1 reference

Assembly and function of RNA silencing complexes

21 January 2018

1 reference

bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA

21 January 2018

1 reference

MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer

21 January 2018

1 reference

The role of microRNAs in normal and malignant hematopoiesis

21 January 2018

1 reference

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma

21 January 2018

1 reference

miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer

21 January 2018

1 reference

Role of miR-155 in breast cancer

21 January 2018

1 reference

High expression of miR-21 and miR-155 predicts recurrence and unfavourable survival in non-small cell lung cancer

21 January 2018

1 reference

MiR-155 inhibits the sensitivity of lung cancer cells to cisplatin via negative regulation of Apaf-1 expression

21 January 2018

1 reference

17β-estradiol up-regulates miR-155 expression and reduces TP53INP1 expression in MCF-7 breast cancer cells

21 January 2018

1 reference

MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling

21 January 2018

1 reference

Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating Wnt/β-catenin signaling

21 January 2018

1 reference

Hepatitis C virus-induced up-regulation of microRNA-155 promotes hepatocarcinogenesis by activating Wnt signaling

21 January 2018

1 reference

Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3.

21 January 2018

1 reference

A role for miR-155 in enabling tumor-infiltrating innate immune cells to mount effective antitumor responses in mice.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.24492

1 reference

29 August 2017

1 reference